We have analyzed the correlation between levels of IL-17+ cells and tumor angiogenesis and with clinical pathological characteristics, and have confirmed that different distribution of IL-17+ cells in tumor tissues was closely associated with patient prognosis. The gene discussed is IL17A; the disease is neoplasm.